Venetoclax and obinutuzumab in chronic lymphocytic leukemia

K Fischer; O Al-Sawaf; A M Fink; M Dixon; J Bahlo; S Warburton; TJ Kipps; R Weinkove; S Robinson; T Seiler; S Opat; C Owen; J Lopez; K Humphrey; R Humerickhouse; E Tausch; L Frenzel; B Eichhorst; CM Wendtner; S Stilgenbauer; Ton Langerak; Jacques Dongen; S Bottcher; M Ritgen; V Goede; M Mobasher; M Hallek

doi:10.1182/blood-2017-01-761973

Venetoclax and obinutuzumab in chronic lymphocytic leukemia

K Fischer, O Al-Sawaf, A M Fink, M Dixon, J Bahlo, S Warburton, TJ Kipps, R Weinkove, S Robinson, T Seiler, S Opat, C Owen, J Lopez, K Humphrey, R Humerickhouse, E Tausch, L Frenzel, B Eichhorst, CM Wendtner, S StilgenbauerTon Langerak, Jacques Dongen, S Bottcher, M Ritgen, V Goede, M Mobasher, M Hallek

Immunology

Research output: Contribution to journal › Article › Academic › peer-review

107 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2702-2705
Number of pages	4
Journal	Blood
Volume	129
Issue number	19
DOIs	https://doi.org/10.1182/blood-2017-01-761973
Publication status	Published - 2017

Research programs

EMC MM-02-72-01

Access to Document

10.1182/blood-2017-01-761973

http://hdl.handle.net/1765/100107

Cite this

Fischer, K., Al-Sawaf, O., Fink, A. M., Dixon, M., Bahlo, J., Warburton, S., Kipps, TJ., Weinkove, R., Robinson, S., Seiler, T., Opat, S., Owen, C., Lopez, J., Humphrey, K., Humerickhouse, R., Tausch, E., Frenzel, L., Eichhorst, B., Wendtner, CM., ... Hallek, M. (2017). Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood, 129(19), 2702-2705. https://doi.org/10.1182/blood-2017-01-761973

@article{861628830296465eabb217d1e0cd2437,

title = "Venetoclax and obinutuzumab in chronic lymphocytic leukemia",

author = "K Fischer and O Al-Sawaf and Fink, {A M} and M Dixon and J Bahlo and S Warburton and TJ Kipps and R Weinkove and S Robinson and T Seiler and S Opat and C Owen and J Lopez and K Humphrey and R Humerickhouse and E Tausch and L Frenzel and B Eichhorst and CM Wendtner and S Stilgenbauer and Ton Langerak and Jacques Dongen and S Bottcher and M Ritgen and V Goede and M Mobasher and M Hallek",

year = "2017",

doi = "10.1182/blood-2017-01-761973",

language = "Undefined/Unknown",

volume = "129",

pages = "2702--2705",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "19",

}

Fischer, K, Al-Sawaf, O, Fink, AM, Dixon, M, Bahlo, J, Warburton, S, Kipps, TJ, Weinkove, R, Robinson, S, Seiler, T, Opat, S, Owen, C, Lopez, J, Humphrey, K, Humerickhouse, R, Tausch, E, Frenzel, L, Eichhorst, B, Wendtner, CM, Stilgenbauer, S, Langerak, T, Dongen, J, Bottcher, S, Ritgen, M, Goede, V, Mobasher, M & Hallek, M 2017, 'Venetoclax and obinutuzumab in chronic lymphocytic leukemia', Blood, vol. 129, no. 19, pp. 2702-2705. https://doi.org/10.1182/blood-2017-01-761973

TY - JOUR

T1 - Venetoclax and obinutuzumab in chronic lymphocytic leukemia

AU - Fischer, K

AU - Al-Sawaf, O

AU - Fink, A M

AU - Dixon, M

AU - Bahlo, J

AU - Warburton, S

AU - Kipps, TJ

AU - Weinkove, R

AU - Robinson, S

AU - Seiler, T

AU - Opat, S

AU - Owen, C

AU - Lopez, J

AU - Humphrey, K

AU - Humerickhouse, R

AU - Tausch, E

AU - Frenzel, L

AU - Eichhorst, B

AU - Wendtner, CM

AU - Stilgenbauer, S

AU - Langerak, Ton

AU - Dongen, Jacques

AU - Bottcher, S

AU - Ritgen, M

AU - Goede, V

AU - Mobasher, M

AU - Hallek, M

PY - 2017

Y1 - 2017

U2 - 10.1182/blood-2017-01-761973

DO - 10.1182/blood-2017-01-761973

M3 - Article

C2 - 28325865

SN - 0006-4971

VL - 129

SP - 2702

EP - 2705

JO - Blood

JF - Blood

IS - 19

ER -